|Videos|September 30, 2020
The future of telemedicine and its reimbursement
Author(s)Jeff Bendix, Senior Editor, Logan Lutton
Patient demand for telemedicine will remain after the COVID-19 pandemic, and as a result more payers will reimburse for it
Advertisement
David Zetter, founder of Zetter HealthCare LLC, says patient demand for telemedicine will remain after the COVID-19 pandemic, and as a result more payers will reimburse for it.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Medical Economics
1
FTC: Express Scripts settlement signals major shift in insulin pricing, PBM oversight, pharmacy transparency
2
Federal spending plan: Follow the money to find winners in health care
3
Affordable drug advocates claim victory over pharmacy benefit managers in budget bill
4
Workplace violence is a business risk: CENTEGIX’s Andrea Greco on safety and staffing in health care
5